Back to News
Market Impact: 0.2
Sales of Leqembi® totaled 32.2 billion yen in the third quarter 2026
Source: PR Newswire
Healthcare & BiotechCorporate EarningsCompany Fundamentals
Eisai published preliminary global Leqembi sales for Q3 2026 alongside Biogen’s third-quarter report. The article excerpt reports sales of JPY 32.2… but is truncated, so the complete amount and any comparison or growth rate are unavailable.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- What investors need to know about Alphabet's stock-busting earnings report
- Our next steps for Alphabet stock after earnings disappoint at nearly every turn
- SK Hynix says the memory-chip shortage will last until 2030—and more than half its production is booked for the next two years
- China’s tech darlings are losing their shine. Here’s what’s behind the sell-off
- GE Vernova shares slip despite a beat-and-raise. What the sellers are getting wrong
- Asian shares fall as Alphabet earnings miss drags Wall St futures lower